BPSA Summit Postponed for Fall 2020 After COVID-19 Outbreak
The decision comes after a state-of-emergency was declared in Washington, DC, due to the ongoing outbreak of COVID-19.
On March 16, 2020, Kevin Ott, director of the Bio-Process Systems Alliance (BPSA) announced in an email to BPSA members and contacts that the BPSA Summit scheduled for July 15–17, 2020 in Washington, DC, will be postponed for a later date in fall 2020. The decision comes after a state-of-emergency was declared in Washington, DC, due to the ongoing outbreak of COVID-19.
“The decision to postpone our 10th Anniversary BPSA Summit was not an easy one to make, but we believe this is the proper course of action given the uncontrollable externalities we all face at the moment,” Ott said in the email. “We believe this to be a prudent business decision, and it is unanimously supported by the BPSA [e]xecutive [c]ommittee.”
Source: BPSA
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
